40 results
Page 2 of 2
6-K
EX-99
slsox36i bo9
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-99
cmt51yn
5 Nov 19
BioLineRx Announces BL-8040 in Combination with KEYTRUDA Shows Clinical Activity in Heavily Pretreated
9:00am
6-K
EX-99
vro73x
5 Nov 19
BioLineRx Presents Preclinical Data from Triple Combination
8:00am
6-K
EX-1
s04 tk2bo2m
28 May 19
Current report (foreign)
7:04am
6-K
EX-99
4y9wdjwn
27 Mar 19
BioLineRx Announces Successful Engraftment Data
7:01am
6-K
EX-99
r4w1r0 1gdldpm
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99.1
t4l t8ynuzjrs
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.3
qn2rgjx btvudoo
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-99
zttacv 6sogfvd
7 Aug 18
BioLineRx Announces Positive Results of Lead-in Period
7:00am
20-F/A
EX-4.40
jof16hk4qimhw135p
31 May 16
Annual report (foreign) (amended)
12:00am
6-K
EX-99
v1ywu4f64j10 0ewx2y
16 Dec 13
BioLineRx Announces Promising Initial Phase 2
12:00am
6-K
EX-10.1
r69u10f3urf
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
F-6
EX-1
781vczjfnz
6 Jul 11
Registration for ADRs (foreign)
12:00am
20FR12B
EX-4.17
qfsu20rf
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
EX-10.17
jk1k5tmjz3w8ua6a rc
24 Sep 10
Registration statement (foreign)
12:00am